Product Description
This combination peptide features Semaglutide (GLP-1 receptor agonist) and Cagrilintide (Amylin receptor agonist) in a synergistic formulation designed for advanced metabolic research.
Both peptides are manufactured to pharmaceutical standards with 99%+ purity, providing a powerful dual-mechanism approach for comprehensive metabolic investigations.
The combination leverages complementary pathways to create an enhanced research tool for studying appetite regulation, glucose homeostasis, and body weight in research models.
Specifications
Purity:99%+
Methodology:HPLC
Storage:2-8°C
Form:Lyophilized Powder
Features
- Dual mechanism
- GLP-1 and Amylin agonists
- Synergistic effects
- Advanced metabolic research
Research Areas
Metabolic ResearchAppetite RegulationGlucose HomeostasisBody Weight